Onconetix, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 0.586 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.31M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men’s health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.
Details
| Name | Onconetix, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 2 |
| Founded | 2018 |
| Ipo Date | 2022-02-18 |
| Ceo | David White |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 9.00 |
| Isin | US68237Q4010 |
| Cusip | 68237Q401 |
| Cik | 1782107 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| David Allan White C.A., C.P.A., ICD.D | Chief Executive Officer |
| Karina M. Fedasz | Interim Chief Financial Officer |
| Andrew D. Skibo Ph.D. | Global Head of Biologics Operations |
| Theodore Scott Yoho | Head of Business Development |
| Dr. Ali I. Fattom Ph.D. | Head of Science and Discovery |
| Dr. Jay Newmark M.B.A., M.D. | Chief Medical Officer |
Contact
| Address | 201 East Fifth Street, Suite 1900, Cincinnati, Ohio 45202, United States |
| Phone | 513 620 4101 |
| Website | https://www.onconetix.com |